Company intelligence / Profile preview
CS Pharmaceuticals
London, United Kingdomcspharmaceuticals.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
CS Pharmaceuticals (CSP) is a UK-headquartered specialty pharma company focused on innovative ophthalmology and rare disease products, aiming to become the leading licensing/commercialization partner for bringing Western specialty drugs to China. CSP's lead program, CSP-270, for Meibomian gland dysfunction, has achieved positive phase II results, and the company has a rare disease product for cystic fibrosis approved in pilot zones in China. CSP is rapidly growing its portfolio through licensing and partnerships with Western biotech and pharma firms.[3][4][5][7]
- Therapeutic areas
- Rare DiseasesOphthalmologyPulmonology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on CS Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CS Pharmaceuticals.